test program

THURSDAY MORNING

8.00 – 9.30

* SALA MARE

CURS SRGH/SNFGE Medical and Surgical Complexity Mircea Diculescu, Pierre Coulom

„Epidemiology and environmental factors in Crohn’s Disease” Philippe Seksik, France

“Management algorithms in Crohn’s Disease” Guillaume Bonnaud, France

“The place of Minimal Invasive surgery in IBD” Oana Stanciulea

* SALA STUDIO

CURS BEST OF EASL

“EASL HCV treatment recommendations” Jean Michel Pawlotsky, France

“From Guidelines to Reality: From individual cure to HCV elimination in Romania by  2030”Liana Gheorghe

“EASL HBV clinical practice guidelines” Massimo Levrero, France

“Treatment update for Delta Hepatitis” Speranța Maria Iacob

* SALA PICTURA

CURS SRED

“Which endoscopic consensus classifications on upper GI diseases are useful in real life?” – Daniela Dobru

“Tips and tricks for upper non-variceal bleeding” – Adrian Goldiș

“How to make polypectomy safe and efficiently?” – Cristian Gheorghe

* SALA MEDIA –

* SALA ATELIER –

                             

09.30 – 10.00 Coffee break

10.00 – 11.30

* SALA MARE

CURS / SRGH (Adrian Goldiș, Philippe Seksik)

“Fulminant Ulcerative Colitis – diagnostic criteria therapeutic challenges” Carmen Preda

“Fistulising Crohn’s Disease” Mirela Ionescu, Cristian Tiereanu

“New Surgical Therapy in perianal Crohn’s Disease” Pierre Coulom, France

* SALA STUDIO

CURS BEST OF EASL

“EASL clinical on practice guidelines the management of patients with NASH” Carmen Fierbințeanu Braticevici

“EASL clinical practice guidelines on non-invasive assessment of liver disease severity and prognosis” Ioan Sporea

“Best of ILC 2017: Cirrhosis and hepatocellular carcinoma “-Mattias Mandorfer

* SALA PICTURA

CURS SRED

“State of the art of PEG technique for avoiding complications” – Gabriel Constantinescu

“Common bile duct stones removal – basic endoscopic techniques” – Eugen Dumitru

“What is evidence based in EUS drainage for pancreatic pseudocyst?” – Adrian Săftoiu

“SEMS for esophageal and biliary malignancy” – Marcel Tanțău

* SALA MEDIA –

* SALA ATELIER –

 

11.40- 13.00

* SALA MARE

SESIUNEA PLENARA

11.40 – 12.00 – Opening Ceremony

12.00-12.20OCTAVIAN FODOR” LECTURE. Prof.  Mircea Grigorescu “Fascinating story of hepatitis C virus infection”

12.20-12.40TIBERIU SPÂRCHEZ” LECTURE. Prof. Alexandru Oproiu “Surveillance of digestive cancers in the gastroenterologist practice”

12.40-13.00 RISING STARS.

* SALA STUDIO –

* SALA PICTURA –

* SALA MEDIA –

* SALA ATELIER –

 

THURSDAY AFTERNOON

13.00 – 14.00 Lunch break

14.00 – 15.30

* SALA MARE

Controversies in Gastroenterology (Oliviu Pascu, Mircea Diculescu)

  1. Follow-up of compensated (F4) liver cirrhosis patients after interferon free therapy.
    • Diculescu: follow-up is a must
    • Sporea: follow up of fibrosis evolution (involution?)
    • Gheorghe: the effect of sustained virological response on the risk for decompensated cirrhosis and hepatocelular carcinoma
  2. Colorectal polyps: pre-polypectomy assessment
    • Pascu: different polyps warrant different approaches?
    • Tanțău: Yes
    • Dumitru: No

* SALA STUDIO

Proton pump inhibitors: half a century since discovery (Carol Stanciu, Cătălin Sfarti)

  1. PPIs-the story of a fantastic therapeutic success. Carol Stanciu
  2. Efficacy and safety of long-term use of PPIs in acid- related diseases. Alina Tanțău
  3. Long-term therapy with PPIs: risk for digestive cancer? Catalin Sfarti
  4. Potential risks associated with long-term use of PPIs. Irina Gîrleanu.
  5. PPIs-a story of success, but a problem of excess. Ana Maria Sîngeap
  6. Carol Stanciu

* SALA PICTURA

Colon cancer: prevention, detection and management (Cristian Gheorghe, Simona Bățaga)

  1. The role of colonoscopy in screening patients with standard risk for colorectal cancer – Eugen Dumitru
  2. The role of colonoscopy in screening patients with high risk for colorectal cancer – Simona Bățaga
  3. Interval cancer – how to minimize the risk? – Cristian Gheorghe
  4. The role of colonoscopy in surgical management of patients with colorectal cancer – Răzvan Iacob

* SALA MEDIA

Radu Badea, Petru Mircea, Ioan Sporea – digestive ultrasound workshop

* SALA ATELIER –

15.40 – 17.10

* SALA MARE

Approved therapies for chronic HCV infection GT1 (Liana Gheorghe, Radu Voiosu)

  1. How to treat patients with HCV-related cirrhosis in 2017? – Radu Voiosu
  2. HCV therapy in special populations: decompensated cirrhosis and advanced renal impairment – Liana Gheorghe
  3. Should we treat patients with low-fibrosis? – Corina Pop
  4. Impact of antiviral therapy on the long-term outcome of liver disease – Speranța Iacob
  5. Improvement of HCV-related extrahepatic disease after achieving SVR – Laurențiu Micu

* SALA STUDIO

Fibrogenesis in digestive diseases: targets of prevention and therapy.  (Alexandru Oproiu)

  1. Alexandru Oproiu
  2. Fibrogenesis of the liver.  Alexandru Oproiu
  3. Fibrogenesis of the pancreas. Mircea Manuc
  4. Fibrogenesis in Crohn’s Disease. Carmen Preda
  5. Fibrous tissue and fibrosis healing. Gabriel Becheanu

* SALA PICTURA

Digestive Hemorrhage (Marcel Tanțău, Eugen Dumitru)

  1. Endoscopy for upper non-variceal gastrointestinal bleeding: where are we in 2017 Eugen Dumitru
  2. Prevention and treatment of variceal bleeding after Baveno VI Daniela Matei
  3. Obscure and occult gastrointestinal bleeding Bogdan Mateescu
  4. Organizing an emergency gastrointestinal endoscopy room. Catalin Sfarti
  5. Radiation enteritis and proctitis. Diagnostic and management. Lidia Ciobanu.
  6. {OP} (8 min).

* SALA MEDIA

                                Radu Badea, Petru Mircea, Ioan Sporea – digestive ultrasound workshop

* SALA ATELIER –

 

17.10 – 17.30 Coffee break

17.30 – 19.30 Pharma symposia

* SALA MARE

17.30-18.30 GILEAD 60’, Prof. I. SporeaTherapeutic Update in HCV
Jean Michel Pawlotsky, HCV treatment advances: clinical and real world data

18.30-19.00 MSD 30’, Prof. L. Gheorghe , Prof. Dr. Daniela Dobru, „Our engagement for a Hepatitis C-free Romania”

19.00-19.30 SODIMED 30’, “News in the long-term control of abdominal pain in Irritable Bowel Syndrome”
Prof. M. Diculescu, Prof L. Gheorghe, Prof Pierre Coulom, France

* SALA STUDIO

17.30-18.00 BMS 30’ “Hepatitis B treatment now and in the future” Prof L. Gheorghe

18.00- 18.40 ALFA WASSERMANN 40’ “10 % Human … 90% Microbiota – The balance of a perfect health”

TARGET 3 study: Why should we retreat the patients with the same antibiotic? Prof. C. Gheorghe

“ZirComBi® – Sinergy for a new equilibrium!” –  Prof. S. Bățaga

18.40-19.10   ABBVIE  30’, “CALM and INSPIRATION in IBD” chair C. Gheorghe Speakers:  Conf. Dr. Lucian Negreanu,   Prof. Dr. Dan Gheonea

* SALA PICTURA

17.30-18.00 BERLIN CHEMIE 30’ Irritable Bowel Syndrome – New Horizons 2017 Prof. M.  Diculescu

* SALA MEDIA –

* SALA ATELIER –

 19:30 Cocktail Foaier Sala Mare


FRIDAY MORNING

8.00 – 8.30 Pharma symposia

* SALA MARE

08.00-08.30 MSD 30’, New perspectives for improved management of inflammatory bowel diseases Prof. C. Gheorghe , Prof. A. Goldis

* SALA STUDIO

ZENTIVA 30’, “Irritable bowel remains functional disease?” Dr. D. Pitigoi

* SALA PICTURA

08.00-08.15 SOLACIUM 15’ Fierul Sucrosomial®: maximal efficacy–tolerability reached target in oral iron therapy Dr. L. Negreanu

08.15-08.30 FITER PHARMA 15’ “Last generation of hepatoprotection in liver disease” Dr. Cătălina Mihai

* SALA MEDIA –

* SALA ATELIER –

 

8.30 – 10.00

* SALA MARE

Colorectal cancer – controversies in all stages, from screening to metastatic stage (Adina Croitoru, Mircea Manuc)

  1. Screening for colorectal cancer, multiple controversies Mircea Mănuc
  2. Stage 2 colon cancer – clarifying controversies? Adina Croitoru
  3. Consensus and controversies in resection of liver metastases from colorectal cancer Irinel Popescu
  4. Intraarterial chemotherapy vs. TACE vs. TARE in hepatic metastases of colorectal cancer Radu Dumitru
  5. Immunohistochemistry in the choice of treatment in metastatic colorectal cancer: all-RAS, BRAF, MSI, her-2-neu. Iulia Gramaticu

* SALA STUDIO

Current therapies for chronic HBV infections (Ion Rogoveanu, Ciprian Brisc)

  1. State of the Art: What’s new in hepatitis B management in 2017″ Liana Gheorghe
  2. Fibrosis evolution in long term nucleoside/ nucleotide therapy in chronic HBV infection. Ciprian Brisc
  3. When to stop nucleoside/ nucleotide therapy in chronic HBV infection? Dan Gheonea, Ion Rogoveanu
  4. Is therapy useful in the immune tolerance phase of hepatitis B infection? Carmen Fierbințeanu Braticevici

* SALA PICTURA

Neurogastroenterology (Vasile Drug, Adrian Goldiș, Dan Dumitrascu)

  1. The approach of chronic diarrhea. Heinz Hammer, Austria
  2. The pragmatic approach to investigate esophageal symptoms. Radu Tutuian, Switzerland
  3. High-resolution manometric and demographic characteristics of patients with non-obstructive dysphagia in a tertiary gastroenterology center. Ion Băncilă, Anca Dimitriu, Cristian Gheorghe
  4. Heart and GERD interactions. Drug V, Floria M, Oana Barboi
  5. Useful tools in differentiating IBS from IBD. Adrian Goldiș
  6. Diverticulosis of the colon: DICA endoscopic classification. Simona Grad, Antonio Tursi, Italy and Dan Dumitrașcu

* SALA MEDIA

Oral presentations (Carmen Preda, Ana Maria Sîngeap)

  1. {OP} 22G STANDARD NEEDLE EUS-FNA CORE HISTOLOGY IN PRACTICE PERFORMANCE EVALUATION. Marcel GHEORGHIU, Ofelia MOSTEANU, Radu Seicean, Andrada SAMARGHITAN, Teodor ZAHARIE, Andrada SEICEAN
  2. {OP} AUTOIMMUNE LIVER DISEASES – SPECTRUM OF CLINICAL PRESENTATION. Ana-Maria Sîngeap, Anca Trifan, Laura Huiban, Cristina Muzica, Sidonia Paula Bucătaru, Irina Gîrleanu, Ștefan Chiriac, Tudor Cuciureanu, Oana Mălinoiu, Monica Jurcău, Diana Arsine, Alina Leuștean, Cătălin Anton, Ciprian Ciorcilă, Carol Stanciu
  3. {OP} COMPARISON OF THE SCORING SYSTEMS USED IN NON-VARICEAL UPPER DIGESTIVE BLEEDING FOR ASSESSING PATIENT’S PROGNOSIS AND THEIR ACCURACY. Daniela Lazăr, Ioan Sporea, Denisia Tornea, Liliana Girboni, Cristina Filip1, Virgil Ardelean, Raluca Lupuşoru, Ioan Romoşan, Adrian Goldiş
  4. {OP} COMPLICATIONS IN PERCUTANEOUS ENDOSCOPIC GATROSTOMY AND JEJUNAL EXTENSION IN PATIENTS WITH ADVANCED PARKINSON’S DISEASE. Moga Tudor, Ratiu Iulia, Savu Laura, Baltes Nicoleta, Popescu Alina, Strain Mihnea, Dan Flavius, Jianu Dragos Catalin, Simu Mihaela, Sporea Ioan
  5. {OP} CONTRAST-ENHANCED ULTRASOUND PERFORMANCE IN THE EVALUATION OF FOCAL NODULAR HYPERPLASIA IN A MULTICENTER STUDY. Roxana Şirli, Ioan Sporea, Daniela Larisa Săndulescu, Alina Popescu, Mirela Dănilă, Tudor Moga, Adrian Săftoiu, Zeno Spârchez, Cristina Cijevschi, Simona Ioanitescu, Dana Nedelcu, Iulia Simionov, Ciprian Brisc, Radu Badea
  6. {OP} CONTROLLED ATTENUATION PARAMETER OF A COHORT OF PATIENTS WITH CLD ADMITTED IN A HEPATOLOGY TERTIARY CENTER. Speranta Iacob, Iuliana Pirvulescu, Razvan Iacob, Cristian Gheorghe and Liana Gheorghe
  7. {OP} CORRELATION OF HIGH RESOLUTION MANOMETRY METRICS WITH SYMPTOMS IN DIFFERENT TYPES OF ACHALASIA. Anca Dimitriu, Ion Băncilă, Cristian Gheorghe
  8. {OP} EFFECTS OF PREBIOTICS ON NON-ALCOHOLIC FATTY LIVER DISEASE. Otilia Gavrilescu, Alexandra Savin, Ana Maria Chiosa, Andreea Dorobăţ, Cătălina Mihai
  9. {OP} HVPG AND TRANSIENT ELASTOGRAPHY ARE THE BEST PROGNOSTIC FACTOR IN PATIENTS WITH HEPATOCELLULAR CARCINOMA SUBMITTED TO HEPATIC RESECTION. Bogdan Procopet, Emil Mois, Adelina Horhat, Anca Bugariu, Horia Stefanescu, Florin Graur, Marcel Tantau, Nadim Al Hajjar
  10. {OP} LOW LYSOPHOSPHATIDYLCHOLINE LEVELS MAY PREDICT SEVERE ALCOHOLIC HEPATITIS. Petra Fischer, Corina Hebristean, Adelina Horhat, Crina Grigoras, Anca Bugariu, Bogdan Procopet, Marcel Tantau, Carmen Socaciu, Horia Stefanescu
  11. {OP} NO HBV REACTIVATION AND NO LIVER DECOMPENSATION OCCURRED IN PATIENTS WITH COMPENSATED LIVER CIRRHOSIS AND HBV+HCV COINFECTION TREATED WITH PARITAPREVIR / OMBITASVIR /R DASABUVIR WITH RIBAVIRIN. Carmen Preda, Corneliu Petru Popescu, Ileana Constantinescu, Doina Proca, Mircea Manuc, Letitia Tugui, Adriana Andrei, Alice Nisanian, Radu Voiosu, Emanoil Ceausu, Mircea Diculescu, Alexandru Oproiu
  12. {OP} NONINVASIVE METHODS OF DIAGNOSING ESOPHAGEAL VARICES IN PATIENTS WITH CIRRHOSIS. Adrian-Răzvan Peagu, Ana Necula, Alexandru Moldoveanu, Roxana Săraru, Ana Petrișor, Gabriela Oprea, Eliza Sârbu, Carmen Fierbințeanu
  13. {OP} PREVALENCE OF ANEMIE IN PATIENTS WITH IBD: A NATIONAL MULTICENTRIC STUDY BASED IN IBD PROSPECT. Stroie T, Lupu A, Stefan Ioana, Hurduc Anca, Fulger Larisa, Cijevschi Cristina, Mihai Catalina, Gheorghe Liana, Gheorghe C., Tantau Alina, Goldis A., Ilie Madalina, Iacob R., Diculescu M
  14. {OP} PREVALENCE OF SESSILE SERRATED ADENOMAS/POLYPS AND THE RISK OF COLORECTAL CANCER. Razvan Opaschi, I. Macarie, Imola Torok, Andreea Golea, Macarie, Simona Roman, Teodora Samoca, M.Ciorba, Simona Bătagă
  15. {OP} THE SIGNIFICANCE OF OCT4 AND SOX2 REPROGRAMMING FACTORS EXPRESSION IN HEPATOCELLULAR CARCINOMA OCCURING ON LIVER CIRRHOSIS. Iacob R, Popa C, Herlea V, Becheanu G, Nastase A, Ghetea L, Iacob S, Botea F, Dima S, Croitoru A, Gheorghe C, Ott M, Popescu I, Gheorghe L
  16. {OP} YOUNG AGE AND MULTIPLE ERCP SESSIONS ARE POSITIVE PROGNOSTIC FACTORS OF RESPONSE TO ENDOSCOPIC TREATMENT IN PAINFUL CHRONIC PANCREATITIS – RETROSPECTIVE OBSERVATIONAL STUDY FROM A TERTIARY REFERRAL CENTER. Alina Tantau, Alina Mandrutiu, Daniel-Corneliu Leucuta, Lidia Ciobanu, Marcel Tantau

* SALA ATELIER –

10.00 – 10.30 Coffee break

10.30 – 12.00

* SALA MARE

Digestive lymphoma at the meeting point of hematology and gastroenterology (Anca Lupu, Cătălina Mihai)

  1. Malignant lymphomas, diagnostic and therapeutic considerations. Anca Roxana Lupu 20 min
  2. Gastric lymphomas
    • Clinical case. Oana Stanca
    • Up-to-date. Maria Ciocîrlan
  3. Chronic hepatitis associated lymphomas
    • Clinical case. Carmen Șaguna
    • Up–to–date. Dan Gheonea
  4. Inflammatory bowel disease associated lymphomas
    • Clinical case. Otilia Gavrilescu
    • Up-to-date. Cătălina Mihai, Cristina Cijevschi Prelipcean
  5. Discussions, conclusions.

* SALA STUDIO

Acute on chronic liver failure (ACLF): frequently met, seldom recognized (Anca Trifan, Irinel Popescu, Camelia Cojocariu)

      1. ACLF-the concept Anca Trifan
      2. How much is known about ACLF by Romanian gastroenterologist/hepatologist? Camelia Cojocariu
      3. The management of ACLF in a gastroenterology unit. Laurentiu Micu
      4. Acute hepatic failure program: could help? Dana Tomescu, Mihai Popescu
      5. Liver transplantation for ACLF. Irinel Popescu
      6. {OP} Stefan Chiriac, Anca Trifan, Ana-Maria Singeap, Tudor Cuciureanu, Oana Stoica, Carol Stanciu. Comparison between Child-Pugh, MELD and the CLIF Consortium acute-on-chronic liver failure scores in predicting mortality in cirrhotic patients with acute-on -chronic liver failure
      7.{OP} Raluca Lupusoru, Ioan Sporea, Alina Popescu, Roxana Sirli, Mirela Danila, Ana-Maria Stepan, Anda Pascaru, Andreea Barbulescu, Iulia Ratiu. Mortality predicting model in liver cirrhotic patients
     8. Irinel Popescu, Anca Trifan Conclusions

* SALA PICTURA

Diagnostic and therapeutic challenges in endoscopy (Adian Goldiș, Andrada Seicean)

  1. Antithrombotic therapy in patients undergoing gastrointestinal endoscopy. Andrada Seicean
  2. The Serrate polyps- a challenge for the endoscopist. Cristian Gheorghe
  3. Endoscopic therapy for obesity. Adrian Goldiș
  4. Stenting of the digestive fistula and leaks. Eugen Dumitru
  5. {OP} 1-2 lucrări acceptate pentru prezentare orală

* SALA MEDIA

Research Projects of SRGH

  1. INTERNATIONAL UEG-SRGH PROJECT: THE EUROPEAN REGISTRY ON  AUTOIMMUNE HEPATITIS. THE ROMANIAN STUDY GROUP ON AUTOIMMUNE                                                           HEPATITIS – INVESTIGATOR MEEING.

Coordinating members: International: Rodrigo Liberal, UK and Ynto S de Boer, USA;  SRGH: Dan Dumitrașcu, Simona Vălean

  1. INTERNATIONAL GERMAN-ROMANIAN PROJECT: GASTRIC CANCER – GWAS.

THE ROMANIAN STUDY GROUP ON GASTRIC CANCER-GWAS – INVESTIGATOR   MEETING.

Coordinating members: International:  Johannes Schumacher, Deutschland; SRGH: Dan Dumitrașcu, Simona Valean

* SALA ATELIER –

FRIDAY AFTERNOON

12.00 – 13.00 Lunch break

13.00 – 14.30

* SALA MARE

Controversies in IBD (RCCC) (Cristina Cijevschi, Alina Tanțău)

  1. Mucosal healing in ulcerative colitis – ideal therapeutic target!
    • Clinical case – Otilia Gavrilescu
    • Pro – Cătălina Mihai
    • Con – Andrada Seicean
  2. LOSS   OF  RESPONSE to biological therapy – through levels and antibodies are mandatory!
    • Clinical case – Roxana Zaharie
    • Pro – Alina Tanțău
    • Con –
  3. Stenosis in Crohn disease – the best option is surgery!
    • Clinical case – Loredana Goran
    • Pro – Lucian Negreanu
    • Con – Bogdan Mateescu
  4. The influence of intestinal microbiota – useful in IBD in remission
    • Clinical case – Anca Dimitriu
    • Pro – Theodor Voiosu
    • Con – Alexandru Lupu

* SALA STUDIO

Diagnosis of hepatocellular carcinoma (HCC) –  Mircea Grigorescu, Zeno Spârchez

  1. Diagnostic possibilities in HCC: from clinomics to genomics and metabolomics –Mircea Grigorescu
  2. HCC in various clinical-pathological settings –Liana Gheorghe
  3. The role of CEUS-LI-RADS system in the standardization of diagnosis of HCC– Zeno Spârchez
  4. Serological diagnosis of HCC –Răzvan Cerban
  5. Histological and immunohistochemical diagnosis of HCC –Gabriel Becheanu
  6. Molecular signature of HCC –Răzvan Iacob
  7. The role of metabolomics in diagnosis of HCC –Horia Ștefanescu
  8. Is portal hypertension assessment a predictive factor in HCC? –Bogdan Procopeț

* SALA PICTURA

Advances in diagnostic and therapeutic challenges in EUS (Adrian Săftoiu, Mariana Jinga)

  1. Clinical impact of EUS in digestive cancers, Mihai Ciocîrlan
  2. Contrast-enhanced harmonic EUSAndrada Seicean
  3. How to improve the diagnostic accuracy in EUS-FNAMariana Jinga, Vasile Daniel Balaban
  4. Interventional EUS, Adrian Săftoiu
  5. {OP} The accuracy of pancreatic solid tumors diagnostic using contrast EUS, Sămărghițan Andrada, Rusu Ioana, Seicean Radu, Nadim Al-Hajjar, Pojoga Cristina, Gheorghiu Marcel, Seicean Andrada.
  6. {OP} Differentiation of pancreatic cyst by contrast-enhanced EUS, Olar Miruna, Mosteanu Ofelia , Pop Teodora , Rusu Ioana,  Seicean Andrada.
  7. {OP} A clinical model to predict pancreatic neuroendocrine tumors histology using EUS characteristics. Saizu A, Iacob R, Dumbravă M, Becheanu G, Pietrareanu C, Gheorghe C

* SALA MEDIA

Nutrition in digestive diseases (Ioana Grințescu, Liana Gheorghe)

  1. Therapeutic options in short bowel syndrome – Liliana Mirea
  2. Role of glutamine in the maintenance of intestinal function – Ioana Marina Grințescu
  3. Gluten-free diet in celiac disease and non-celiac gluten sensitivity – Liana Gheorghe
  4. Low FODMAPs diet: principles, indications, efficacy – Cătălina Mihai
  5. {OP} Steatosis and liver fibrosis assessment in liver transplant recipients – the use of non-invasive scoring systems in clinical practice. Carmen Ester, Speranța Iacob, Corina Pietrăreanu, Răzvan Cerban, Mihaela Liță, Doina Hrehoreț, Vladislav Brașoveanu, Irinel Popescu, Liliana Pâslaru, Georgiana Constantin, Liana Gheorghe.

* SALA ATELIER

Videosession SRED: How to do it?

Chairmen:Cristian Gheorghe, Eugen Dumitru

  1. Band ligation for variceal bleeding. Bogdan Cotruta
  2. SEMS for esophageal malignancy. Marcel Tantau, M.Voicu
  3. Endoscopic therapy for bleeding ulcer. Tatiana Ivan, Sergiu Cazacu
  4. Colonic polypectomy. Catalin Sfarti
  5. Endoscopic sphincterotomy for biliary stones. Eugen Dumitru
  6. EUS-FNA for pancreatic cysts. Mihai Ciocirlan

 

14.40 – 16.10

* SALA MARE

Acute pancreatitis: prevention and therapy of complications (Andrada Seicean, Adrian Săftoiu)

  1. Local complications in acute pancreatitis. Adrian Saftoiu
  2. Systemic complications in acute pancreatitis. Liliana Mirea
  3. Minimally invasive treatment in acute pancreatitis. Andrada Seicean
  4. {OP} Disease phenotype according to location of inflammation in acute pancreatitis. Balaban Daniel Vasile, Sandu Bianca, Popescu Andrada, Patrasescu Mihaita, Bucurica Sandica, Costache Raluca Simona, Petrut Nuta, Ionita Radu Florentina, Jinga Mariana­
  5. {OP} Predictive factors in acute pancreatitis. L. Savu, M. Strain, M. Laczko, R. Lupusoru, I. Sporea, M. Danila, A. Popescu, F. Bende
  6. SPECIAL LECTURE. Acute pancreatitis: the ten commandments! Prof. Phillippe Levy (30 min)

* SALA STUDIO

Up-Date on portal hypertension (Ioan Sporea, Cristina Cijevschi)

  1. Portal hypertension classification. Alina Popescu
  2. Portal hypertension noninvasive diagnosis. Roxana Sirli.
  3. Portal hypertension invasive diagnosis. Bogdan Procopet.
  4. Medical therapy of portal hypertension. Cristina Cijevschi.
  5. Transjugular intrahepatic portosystemicshunt (TIPS). Bogdan Procopeț.

* SALA PICTURA

Gastric cancer: endoscopic detection, evaluation and treatment (Daniela Dobru, Mihai Ciocîrlan)

  1. Doctor, what is my risk of gastric cancer? Cătălin Sfarti
  2. Can we use biomarkers to predict gastric cancer? The role of serum levels of trefoil factor family proteins. Bogdan Cotruță
  3. Is endoscopy able to identify precursor and early neoplastic gastric lesions? Daniela Dobru
  4. {OP} Endoscopic diagnosis of gastric atrophy and intestinal metaplasia. Viorel Istrate, Nicolae Bodrug, Chișinău
  5. Endoscopic ultrasound in gastric cancer – is it of any use? Alina Tanțău,
  6. Gastric cancer surgery in the era of robotics. Cătălin Vasilescu
  7. Can endoscopic submucosal dissection replace surgery in selected cases? Mihai Ciocîrlan

* SALA MEDIA

Secțiunea Asistente 1

* SALA ATELIER

“Young Talent Group” SRGH section: commencement session.

Moderatori- Mădălina Ilie, Vasile Sandru, Dan Gheonea

  1. European Young Talent Group- Mădălina Ilie
  2. Young Romanian Gastroenterology Group-Cătălina Diaconu, Oana Plotogea
  3. Career tips from a young gastroenterology expert –Dan Gheonea
  4. The experience of young gastroenterologists abroad- Alexandru Lupu 
  5. How to write a paper for successful publication-Bogdan Ungureanu
  6. How to successfully apply for a fellowship – Vasile Balaban

16.10 – 16.30 Coffee break

16.30 – 18.00 Pharma symposia

* SALA MARE

16.30-17.30 ABBVIE 60’ “Clinical Considerations in Treatment of HCV infection” Prof. L. Gheorghe,Prof. Ioan Sporea

17.30-18.00 REDDY’S 30’ Clostridium difficile and the place of Saccharomyces boulardii Prof.M. Guslandi

* SALA STUDIO

16.30-17.10 SANOFI 40’  “screening possibilities and therapeutic management of NAFLD in primary care” Prof D. Dumitrașcu, Prof. A. Trifan, Prof. M Diculescu

17.10-17.40  SECOM 30’ “How to feed your gut bugs!” Conf . A. Plesa

* SALA PICTURA

16.30-17.00 MYLAN 30’ „From guidelines to clinical experience in Pancreatic Exocrine Insufficiency” Prof. A. Săftoiu

17.00- 17.30 SUNWAVEPHARMA 30’  Utilitatea Saccharomyces Cerevisiae CNCM I-3856 in Sindromul de Intestin Iritabil Conf.L. Negreanu

17.30-18.00 INNERGY 30’ Prof L. Gheorghe Intestinal microbiota modulation in IBS – new  perspectives.

* SALA MEDIA

Secțiunea Asistente 2

* SALA ATELIER –

18.00 – 19.30

* SALA MARE

Presidential report Prof. Dan Dumitrașcu

Editor in chief of JGLD report Prof. Monica Acalovschi

SRGH Elections

Prizes and distinctions

* SALA STUDIO –

* SALA PICTURA –

* SALA MEDIA –

* SALA ATELIER –

19.30 Cina Festiva Foaier Sala Mare


SATURDAY MORNING

 

8.00 – 9.00 Pharma symposia

* SALA MARE

08.00-08:30 GILEAD 30” New steps forward in HBV treatment-Conf. Florin Alexandru Caruntu

08.30-09.00 PFIZER 30’ (8.30 – 9.00), Therapeutical objectives and quality of life for the patient with Irritable Bowel Syndrome, Mircea MANUC

* SALA STUDIO

08.00-09.00 IPSEN 60’ “Probiotics: a proactive approach in IBS” Prof .Javier Santos. Prof. D. Dumitrașcu

* SALA PICTURA –

08.30-09.00  ARTM 30’ (8.30-9.00) A WORLD FREE OF HEPATITES C – Overview of Egyptian Hepatites C control programme. Prof. Dr. Wahid Doss

* SALA MEDIA

Long Life Learning Course. ROSPEN. ESPEN (Remy Meier, Raluca Ungureanu)

* SALA ATELIER

9.00 – 10.30

* SALA MARE

New challenges in the treatment of IBD patients (RCCC) (Adrian Goldis, Lucian Negrean)

  1. Introduction and overview of the new therapeutic challenges in IBD. Adrian Goldis
  2. Treat to target and individualized treatment. Lucian Negreanu
  3. Biologic treatment- when to switch, increase or decrease the dose? Daniela Lazar, Adrian Goldiș
  4. When can or should we stop biologic treatment in IBD patients? Toader , M Dranga
  5. {OP} Clinical predictors of aggressive disease Course in Romanian IBD patients: a real-life, long term follow-up, cohort study. Stoica B, Saizu I, Cojocaru M, Dimitriu A, Les A, Stefan A, Lupu A, Iacob S, Vadan R, Gologan S, Gheorghe L, Gheorghe C, Diculescu M, Iacob R
  6. {OP} Correlation between sonographic measurements and biomarkers in IBD. Anada Les, C. Gheorghe.

* SALA STUDIO

Standard of care for neoplastic and non-neoplastic pancreatic diseases in 2017 (APPR) (Cristian Gheorghe, Adrian Săftoiu)

  1. Pancreatic enzyme replacement therapy in chronic pancreatitis. Mariana Jinga
  2. Personalized treatment for pancreatic neuroendocrine tumors. Adrian Saftoiu
  3. Standard of care in IPMN. Andrada Seicean
  4. Accurate stadialization is mandatory for better treatment in pancreatic cancer. Cristian Gheorghe
  5. {OP} Risk factors in pancreatic cancer. Raluca Grigorescu, Cristina Radu, Andra Tonceanu, Adina Croitoru, Cristian Gheorghe.

* SALA PICTURA

Digestive psychosomatics (Dan Dumitrascu, Vlada Dumbrava, Laurentiu Nedelcu)

  1. Endoscopic therapy for obesity. Davor Stimac, Croatia
  2. Digestive symptoms in oncologic patients. Irina Ciortescu
  3. {OP} Psychosocial aspects of Helicobacter pylori gastritis and functional ulcer-like dyspepsia. Paul Porr
  4. Placebo effect in digestive complaints. Laurentiu Nedelcu
  5. Functional diet between myth and reality. Anamaria Cozma, Dan Dumitrascu
  6. {OP} The Impact of Comorbidity of Irritable Bowel Syndrome and GERD on Quality of Life. Alexandru Babin, Chișinău
  7. {OP} O lucrare selectata dintre rezumatele expediate

* SALA MEDIA

Long Life Learning Course. ROSPEN. ESPEN (Remy Meier, Raluca Ungureanu)

* SALA ATELIER –

 

10.30 – 11.00 Coffee break

11.00 – 12.30

* SALA MARE

Alcoholic and non-alcoholic liver disease (Carmen Fierbinteanu, Monica Acalovschi)

  1. Who should be treated and how do we identify NAFLD patients with increased risk for disease progression? State-of-the art lecture. Carmen Fierbințeanu-Braticevici
  2. How do we identify the patients with severe alcoholic hepatitis and how do we treat them? State-of-the-art lecture. Monica Acalovschi
  3. Non-invasive evaluation of fibrosis and steatosis by elastographic methods in fatty liver disease. Monica Platon Lupsor
  4. Recent trends in the epidemiology of alcoholic and nonalcoholic fatty liver disease in Europe and Romania. Corina Pop
  5. Histologic characteristics of alcoholic and non-alcoholic fatty liver disease. Gabriel Becheanu
  6. 13C-octanoic acid breath test in the non-invasive diagnosis of nonalcoholic steatohepatitis (NASH). Original study. Alexandru Moldoveanu
  7. Adipokines and insulin resistance as predictors of gallstone disease and NAFLD in the general population. Original study. Ofelia Moșteanu

* SALA STUDIO

From molecular biology to interventional endoscopy: high end research in Romania (Tudorel Ciurea, Gabriel Constantinescu)

  1. {OP} 99,6% PREVALENCE OF GENOTYPE 1 B IN ROMANIAN PATIENTS WITH ADVANCED FIBROSIS AND CHRONIC HEPATITIS C: DATA FROM GENOTYPING OF 7421 PATIENTS. Carmen Monica Preda*, Corneliu Petru Popescu*, Doina Proca*, Larisa Elena Fulger*, Radu Voiosu*, Mircea Manuc*, Corina Silvia Pop*, Emanoil Ceausu*, Alice Nisanian*, Mircea Diculescu*, Alexandru Oproiu*.
  2. {OP} EFFICACY, SAFETY AND DYNAMIC OF NONINVASIVE FIBROSIS SCORES IN HCV {OP} ENDOSCOPIC ULTRASOUND IMAGING TECHNIQUES FOR THE ASSESSMENT OF INTRAVASCULAR THROMBOSIS RELATED TO MALIGNANT TUMORS. Irina Florina Cherciu , Elena Tatiana Cartana , Daniela Elena Burtea , Mihaela Calita , Anca Vilcea1, Daniela Mititelu, John G. Karstensen , Peter Vilmann , Adrian Saftoiu
  3. LIVER TRANSPLANT RECIPIENTS TREATED WITH INTERFERON-FREE REGIMENS. Speranta Iacob, Irinel Popescu and Liana Gheorghe
  4. {OP} TRAINING IN ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY (ERCP): COMPLICATIONS AFTER A FIRST SERIES OF 50 CASES. Miutescu Bogdan, Nistorescu Silviu, Bende Felix, Barbulescu Andreea, Fofiu Renata, Baldea Victor, Mare Ruxandra, Ratiu Iulia, Strain Mihnea, Goldis Adrian, Sporea Ioan
  5. {OP} TUMOR ABLATION IN DIFFERENT TYPES OF HEPATIC METASTASES. A SINGLE CENTER EXPERIENCE. Tudor Mocan, Pompilia Radu, Florin Graur, Nadim Al Hajjarc, Cornel Iancu, Zeno Sparchez
  6. {OP} ECHOENDOSCOPIC DRAINAGE OF PANCREATIC WALLED-OFF NECROSIS BY USING SELF-EXPANDING METAL STENTS. Marcel GHEORGHIU, Cristina POJOGA, Ofelia MOSTEANU, Teodora POP, Radu Seicean, Al Hajjar NADIM, Vasile ANDREICA, Andrada SEICEAN
  7. {OP} EMERGING PROBLEMS WITH CLOSTRIDIUM DIFFICILE INFECTION IN ACUTE CARE HOSPITALS. A RETROSPECTIVE STUDY REGARDING EPIDEMIOLOGY, RISK FACTORS AND EXPOSURE IN BUCHAREST CLINICAL EMERGENCY HOSPITAL. Teodora Manuc, Gabriel Constantinescu, Diana Diaconescu, Mihaela Rusu
  8. {OP} THE EFFICIENCY OF PANCREATIC STENTS IN DIFFICULT CANNULATION– A RETROSPECTIVE SINGLE-CENTER STUDY. Gabriel Constantinescu, Mădălina Ilie, Oana Plotogea, Ecaterina Rînja, Vasile Şandru

* SALA PICTURA

SRED 6. Legal aspects in digestive endoscopy (Vasile Drug, Sergiu Cazacu)

  1. The informed consent in endoscopy- standard requirements. Gheorghe Bălan
  2. The informed consent in endoscopy- special cases. Sergiu Cazacu
  3. Avoiding medico-legal complications in endoscopy. Cristian Gheorghe
  4. Medical Malpractice in endoscopy: what we getting wrong. Teodora Pop
  5. Relationship between Romanian Societies of Gastroenterology and Romanian College of Physicians –more than medico-legal aspects. Drug V, Oprea L

* SALA MEDIA

Long Life Learning Course. ROSPEN. ESPEN (Remy Meier, Raluca Ungureanu)

12.30-13.30 Sedinta SRED

* SALA ATELIER – 

12.30-13.30 : SRED general assembly
Presidential report Eugen Dumitru
Financial Report Vasile Drug
SRED elections

SATURDAY AFTERNOON

 

14.00 – 16.00 and 16.30 – 18.30

* SALA MEDIA

Long Life Learning Course. ROSPEN. ESPEN (Remy Meier, Raluca Ungureanu)